Application deadline: 16 Aug 2026
Institute: St. Anna Children's Cancer Research Institute
Country: Austria
More information: https://ccri.at/working-at-the-ccri/job-openings/?jh=s1xt37876zlnfzlp29zdgxdk7rntz4m
Where cutting‑edge science meets real clinical decisions, precision oncology makes the difference!
Precision oncology has the power to redefine how children with cancer are diagnosed and treated and at St. Anna Children’s Cancer Research Institute (St. Anna CCRI), we are taking this promise to the next level.
To strategically expand our institutional precision medicine program, we are seeking an outstanding Head of Precision Oncology to shape and lead a flagship initiative at the interface of research, molecular diagnostics, and clinical care. In this role, you will play a pivotal part in translating cutting‑edge molecular insights into individualized treatment strategies for pediatric cancer patients. This position is open to candidates at different career stages.
Key responsibilities
- Establish and lead the institutional precision oncology program: Strategically develop and oversee molecular profiling, functional drug sensitivity testing, and multi‑omics integration in close clinical partnership with the St. Anna Children’s Hospital.
- Build and operate advanced laboratory and analytical infrastructures: Design and manage state‑of‑the‑art platforms ensuring high quality standards, efficiency, and scalability.
- Translate multi‑omics data into clinical decision‑making: Integrate genomic and functional data to enable personalized treatment strategies for pediatric cancer patients.
- Drive innovation and technology development: Implement next‑generation sequencing, data analytics, and functional precision medicine approaches.
- Strengthen translational and clinical trial interfaces: Collaborate closely with the St. Anna CCRI Clinical Trials Unit, the clinical diagnostics laboratory Labdia (St. Anna CCRI subsidiary), and oncology teams (i.e., national and international PIs at the St. Anna Children’s Hospital) to support biomarker-driven studies, patient selection, and early-phase translation.
- Leadership, visibility & sustainability: Build and lead a high‑performing multidisciplinary team, represent the precision oncology program in national and international networks, and secure competitive funding to ensure long‑term sustainability.
Required Qualifications
- PhD or MD/PhD in biomedical sciences, with deep expertise in molecular oncology, genomics, functional drug profiling, or computational precision medicine.
- Several years of experience in leading translational precision medicine programs or multi-omics pipelines.
- Strong technical understanding of sequencing technologies (e.g. WGS, WES, RNA‑seq, long‑read sequencing) and liquid biopsy assays.
- Familiarity with diagnostic workflows, molecular tumor boards, and clinical trial data structures.
- Demonstrated success in securing competitive third‑party funding and leading independent research programs.
- Strong leadership and mentoring skills (incl. education and training), with experience building and managing interdisciplinary teams.
- Excellent collaboration skills at the interface of research, clinical oncology, and diagnostic laboratories.
- Strong publication record and visibility in the field of precision oncology.
- Excellent English skills for scientific, clinical, and operational communication; German is an advantage.
